Neslisah Barlak
Erzurum, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
1,2,3-Triazole-Linked Chalcones as Privileged Scaffolds in Anticancer Agents.
Journal: Archiv der Pharmazie
Published: September 29, 2025
Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer.
Journal: Head & neck
Published: October 26, 2023
Overexpression of POFUT1 promotes malignant phenotype and mediates perineural invasion in head and neck squamous cell carcinoma.
Journal: Cell biology international
Published: November 11, 2022
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 25, 2021
The effects of Daucus carota extract against PC3, PNT1a prostate cells, acetylcholinesterase, glutathione S-transferase, and α-glycosidase; an in vitro-in silico study.
Journal: Journal of food biochemistry
Published: June 10, 2021
MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells.
Journal: Cell biology international
Published: July 31, 2020
Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
Journal: Head & neck
Published: May 21, 2020
The roles of microRNAs in the stemness of oral cancer cells.
Journal: Oral oncology
Published: April 01, 2020
Mode of action of carboplatin via activating p53/miR-145 axis in head and neck cancers.
Journal: The Laryngoscope
Published: October 10, 2019
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.
Journal: Cell biology international
Published: March 04, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026